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1. Introduction
The use of novel illicit drugs and the constant appearance of
new psychoactive substances have rapidly grown in the last
years, and reports of the availability and manufacture of such
substances have increased.[1] Illicit drugs are those for which
nonmedical use has been prohibited by international control
treaties because they are believed to present unacceptable
risks of addiction to users. According to the FDA, these com-
pounds can also be defined as “drugs of abuse”, substances
that are used in a manner or amount inconsistent with the le-
gitimate medical use.[2] The problematic use of these illicit
drugs is associated with considerable mortality and morbidity.
During the last 30 years, international control has been extend-
ed from plant-based drugs (e.g. heroin, cocaine, and cannabis)
to synthetic drugs (e.g. amphetamines, 3,4-methylenedioxyme-
thamphetamine, etc.) and pharmaceutical drugs (e.g. bupre-
norphine, methadone, benzodiazepines, etc.). Specifically, syn-
thetic drugs are proliferating at an unprecedented rate and are
posing significant public health challenges. The majority of
these addictive substances, directly or indirectly, attack the
brain’s reward system, mainly serotonin and dopamine recep-
tors, which regulate movement, emotion, motivation, and,
above all, the feelings of pleasure and euphoria associated
with the consumption of narcotics. Nowadays, amidst all illicit/
abuse substances, cannabis is the most consumed drug world-
wide with 183 million euro incautions, followed by ampheta-
mines and derivatives (37 million euro), opioids (35 million
euro), ecstasy (22 million euro), opiates (18 million euro), and
cocaine (17 million euro). According to their pharmacologic be-
havior, drugs can be divided into depressants, stimulants, hal-
lucinogenic, and opioids.
Because of their harmfulness to health, the ability to detect
and quantify “drugs of abuse” in a fast, easy, and reliable way
is crucial. The United Nations Office on Drugs and Crime
(UNODC) established 28 million years of healthy life lost world-
wide in 2015 because of premature death and disability
caused by drug use.[3] Apart from the health problems generat-
ed by illicit drug consumption, UNODC exposes the existence
of continue evolving organized crime/terrorism related with
drug market. The European homologue, European Monitoring
Centre for Drugs and Drug Addiction (EMCDDA), assumes
there exists an important internet market dedicated to the sale
of illicit substances protected by anonymization services.[4] Last
annual informs of both the UNODCS and EMCDDA emphasized
the necessity to control the production and distribution of
new psychoactive substances (NPSs), as there are no assuran-
ces to the consumers of the compounds contained, and the
need to reinforce the development of new detection systems
with the aim to decrease and eliminate the abuse of traditional
and synthetic emerging drugs.[5] The development of reliable
methods for their detection and quantification is timely and ur-
gently required.
Nowadays, illicit drug detection is performed mostly through
chromatographic techniques, as can be seen by the large
number of research articles published in this field, because of
the excellent features of chromatographic techniques, which
include great versatility, robustness, and sensibility.[6] Several
electrochemical,[7] infrared,[8] Raman spectroscopy,[9] and mag-
netic resonance[1] methods also exist for the detection of sever-
al drugs, and these techniques show excellent results in terms
of selectivity and sensibility. However, they present some short-
comings such as high cost, the use of trained personnel, tedi-
ous sample pretreatment, and so on. As an alternative to these
traditional techniques, the design of molecular probes for the
undemanding chromo- and fluorogenic detection of illicit
drugs can be of importance. Both chromogenic and fluorogen-
ic probes provide several advantages over other traditional an-
alytical techniques, such as their chemical simplicity, ease of
use, rapid response suitable for real-time on-site detection,
easy detection to the naked eye, and so on.[10] Despite these
remarkable features, the development of chromo- and fluoro-
genic sensors for the selective and sensitive detection of cer-
tain illicit drugs is still poorly explored. In this review, a thor-
ough overview of chromogenic and fluorogenic sensing sys-
tems for the detection of most consumed drugs is provided.
The consumption of illicit drugs has increased exponentially in
recent years and has become a problem that worries both
governments and international institutions. The rapid emer-
gence of new compounds, their easy access, the low levels at
which these substances are able to produce an effect, and
their short time of permanence in the organism make it neces-
sary to develop highly rapid, easy, sensitive, and selective
methods for their detection. Currently, the most widely used
methods for drug detection are based on techniques that re-
quire large measurement times, the use of sophisticated equip-
ment, and qualified personnel. Chromo- and fluorogenic meth-
ods are an alternative to those classical procedures.
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The review is organized by the description of probes for differ-
ent drugs classified according to their pharmacologic behavior,
that is, depressants, stimulants, hallucinogenic, and opioids.
Table 1 contains a summary of the different strategies for
the chromo- and fluorogenic detection of illicit drugs used in
the examples described below.
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GBL BODIPY fluorescent sensor water and alcoholic
drinks
3 – [12]





GHB colorimetric sensor water – GBL, 1,4-butanediol, propionic acid, butyric
acid, and common salts
[15]













ketamine colorimetric test water 100 AMP, MAMP, MDMA, cocaine, EPH, scopola-
mine, caffeine, acetaminophen, ibuprofen,











dextromethorphan spectrophotometric method pharmaceuticals
preparations
3.5V10@3 – [23]






cations, anions, ascorbic acid, glucose, urea,
cysteine, glutamic acid, asparagine, leucine,




MA, EPH, and MeEPH formation of colored product urine 3.75V10@3,
4.13V10@3, and
4.48V10@3
CaCl2, NaCl, MgCl, NaNO3, CH3COONa, Al
III,
FeIII, NiII, CoII, NH4
+ , urea, uric acid, creatinine,
and hippuric acid
[26, 27]




2–5 cocaine, cannabinol, cannabidiol, THC, sco-
polamine, EPH, and procaine
[28]
cocaine biomimetic material (AuNPs) absorbent pad – Benzoylecgonine, nicotine, cotinine, codeine,
THC and MA
[29]
MA Simon’s reagent applied to
mobile phone technology
application installed




MDMA bis-diarylurea-based probe ecstasy tablets 2.45V10@5 EPH, PEPH, AMP, MDA, and MDMA [32]






MA molecular recognition (perylene
bisimide fluorophore, and two
cholesterol subunits)
vapor 5.5V10@6 amines, organic solvents, water, apple
pomace
[34]
MDMA NPs water 0.95 cocaine, heroin, methadone, and morphine [35]
MA molecular recognition (amine-
functionalized polyfluorene)
THF 2.5V10@5 pethidine and EPH [36]












MDMA and MDA colorimetric reaction sulfuric acid aque-
ous (75%, w/v)
0.19 – [39, 40]
MA NPs toluene and vapor – o-toluidine, hexylamine, diethylamine, dibu-
tylamine, allylamine, trimethylamine, and
aniline
[41]
catecholamine molecular recognition water – biogenic amines, sugars, neurotransmitters,
and amino acids
[42]
phenothiazine drugs spectrophotometric method sulfuric acid – – [43]
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Table 1. (Continued)
STIMULANT DRUGS
PEA UV n-hexane 10@4 phenylethanolamine [44]
d- and l-a-phenylethyla-
mines
fluorescence chiral sensors MeCN – – [45]







water – – [47]
MA aptasensor combined with AuNPs
(colorimetric assay)
human urine 1.2V10@4 pethidine, triazolam, barbital, morphine, keta-
mine, and diazepam
[49]
MA aptasensor and oxidation reaction
of a fluorophore
water 7.4V10@9 ketamine, norketamine, morphine, metha-




MDMA, EDDP, and mCPP
[50]
cocaine aptamer nanomachine (FRET pro-
cess allowed or not depending
on the analyte)
water 1.5V10@4 – [51]














cocaine aptasensor combined with CQDs
(quenching off/on process)
water 6.1V10@7 benzoylecgonine and ecgonine methyl ester [54]
cocaine aptasensor combined with CQDs
(quenching off/on process)
water 1.5V10@5 [55]
cocaine aptasensor combined with silica
NPs and AuNPs (quenching off/on
process)
water or serum 6.3V10@9 and
8.9V10@9
chloramphenicol, propranolol, diazepam, and
morphine
[56]
cocaine fluorophore quenched by apta-








cocaine aptasensor combined with CQDs
and NPs (quenching off/on pro-
cess)
buffered solution 4.2V10@9 benzoylecgonine, MA, 3-acetamidophenol,
and codeine
[58]
cocaine aptameric molecular gate
(fluorogenic or SERS detection)
Tris solution
(pH 7.5) and saliva
1.5V10@5 morphine and heroine [59, 61]
cocaine aptasensor (quenching off/on
process)
buffered solution 3.0V10@5 benzoylecgonine and ecgonine methyl ester [62]
cocaine aptasensor (quenching off/on
process)
serum 3.0V10@4 benzoylecgonine and ecgonine methyl ester [63]
cocaine aptasensor (molecular displace-
ment of dye and increase in ab-
sorption band)
buffered solution 6.1V10@5 benzoylecgonine and ecgonine methyl ester [64]
cocaine aptasensor (conformation
changes after molecular recogni-
tion of analyte, high fluorescence
anisotropy)
buffered solution 1.5V10@4 theophylline, caffeine, BSA, IgG, arginine,
phenylalanine, and aspartic acid
[65]
cocaine aptasensor (conformation
changes after addition of analyte
in presence of CuNPs)
water 3.0V10@3 ecgonine, pethidine, and methadone [66]
cocaine aptasensor combined with GO
and AuNPs (quenching off/on
process)
plasma and serum 3.0V10@3 pethidine and methadone [67, 68]
cocaine aptasensor combined with AuNPs
(changes in absorption band due
to aggregation of AuNPs)
water 6.1V10@5 – [69, 70]
cocaine aptasensor combined with AuNPs
(changes in absorption band due
to aggregation of AuNPs)
urine and serum 30.3 – [71]
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Table 1. (Continued)
STIMULANT DRUGS
cocaine aptasensor based on G-quadru-
plex/ruthenium complex interac-
tion (decrease in fluorescence in
presence of analyte)
serum 1.5V10@7 caffeine, morphine, and theophylline [72]
cocaine aptasensor grafted onto optical
fiber (quenching off/on process)
serum 5.0V10@6 kanamycin, amikacin, and ibuprofen [73]
cocaine aptasensor combined with AuNPs
(naked-eye detection system)
buffered solution 2.5V10@3 ephedrine, codeine, ketamine, AMP, mor-
phine, MA, benzoylecgonine, and ecgonine
methyl ester
[74]
cocaine aptasensor combined with AuNPs
(changes in absorption band due
to aggregation of AuNPs)
water 1.5V10@3 – [75]
cocaine aptasensor combined with UCNPs
and AuNPs (quenching off/on
process)
saliva 3.0V10@6 benzoylecgonine and ecgonine methyl ester [76]
cocaine aptasensor combined with GO
and a fluorophore (quenching
off/on process)
urine 5.8V10@5 adenosine, caffeine, theophylline, and mor-
phine hydrochloride
[77]
cocaine aptasensor combined with CD
and QDs (quenching on/off
process)
serum 4.0V10@6 MA, codeine, THC, nicotine, cotinine, and
benzoylecgonine
[78]
cocaine and MA aptasensor combined with
Au@AgNPs (changes in absorp-
tion band due to aggregation of
NPs)
buffered solution 1.5V10@7 for co-
caine and 14.9
for MA




cocaine aptasensor based on G-quadru-
plex/iridium complex interaction
(switch-on luminescence)
buffered solution 9.1V10@7 ATP, adenosine, warfarin, and suramin [80]
cocaine aptasensor combined with MNPs buffered solution 1.5V10@5 ecgonine, pethidine, and methadone [81]
cocaine aptamer nanomachine combined
with AgNPs (changes in fluores-
cence band due to aggregation
of AgNPs)
serum 6.1V10@6 ecgonine and benzoylecgonine [82]
cocaine aptasensor (conformation
changes after molecular recogni-
tion of analyte, enhanced fluores-
cence intensity)
buffered solution 6.1V10@6 benzoylecgonine and ecgonine methyl ester [83]
HALLUCINOGENIC DRUGS
LSD fluorescence water and NaOH 2.6V10@4 mg mescaline, DOM, psilocin, psilocybin, bufote-







AuNPs water 5 mmolL@1 – [87]
heroine, morphine, oxy-
codone, and their main
metabolites













[a] LOD: limit of detection; GBL: g-butyrolactone; GHB: g-hydroxybutyric acid; CPH: chlorpromazine hydrochloride; AMP: amphetamine; MA: methamphet-
amine; MDMA: 3,4-methylenedioxymetamphetamine; MDA: 3,4-methylenedioxyamphetamine; EPH: ephedrine; MeEPH: methylephedrine; THC: tetrahy-
drocannabinol; PEPH: pseudoephedrine; DOM: 2,5-dimethoxy-4-methylamphetamine; AMPH: (+)-amphetamine sulfate; METH: (+)-methamphetamine hy-
drochloride; DA: dopamine; PEA: 2-phenylethylamine; EDDP: 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine; mCPP: meta-chlorophenylpiperazine; IgG:
immunoglobulin G; BSA: bovine serum albumin.
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2. Depressant Drugs
Depressant drugs slow down the nervous system and brain ac-
tivity and thus have a sedating effect.[11] Most depressants
affect one of the brain’s neurotransmitters, that is, g-aminobu-
tyric acid (GABA), which upon activation produces a sense of
calm and relaxation. GABA is the chief inhibitory neurotrans-
mitter in the mammalian central nervous system (CNS), and its
principal role is to reduce neuronal excitability. Depressant
drugs have the particularity that often leads to “drug toler-
ance”, which makes the organism ask for higher doses until de-
pendence or overdose arises. Coma, respiratory diseases, and
death are the potential consequences of their continuous con-
sumption. Depressant drugs comprise barbiturates, benzodia-
zepines, alcohol, and g-hydroxybutyrate.
In 2013, Chang and co-workers reported boron–dipyrrome-
thene (BODIPY) fluorescent sensor 3 for g-butyrolactone (GBL)
detection in water and in different alcoholic drinks
(Figure 1).[12] GBL is a prodrug of g-hydroxybutyric acid (GHB),
and its relevance is due to the strong regulation to which GBH
is subject, but this is not applicable to GBL. GBL overdose
causes irrational behavior, severe sickness, coma, and death.[13]
Sensor 3 shows a marked absorption band centered at l=
569 nm in water. Besides, upon excitation at l=569 nm, a
small emission band at l=582 nm (with a low quantum yield
of 0.05) is observed. The addition of GBL to an aqueous solu-
tion of 3 induces an emission enhancement at l=582 nm (
&10-fold). A limit of detection for GBL by using 3 is reported
to be 3 mgmL@1. The off–on emission response is related with
the hydrophobic character of the probe. The authors indicate
that probe 3 forms nonemissive aggregates in water that are
progressively broken upon coordination with GBL with a sub-
sequent enhancement in emission. In addition, probe 3 can be
used to detect GBL in drink samples after a simple extraction
process. The presence of GBL is simply assessed by irradiation
with a green laser pointer; this induces the appearance of
orange fluorescence, which is not observed in samples without
the drug.
The same authors also report on the preparation of BODIPY
probe 4 (Figure 1) for the fluorogenic detection of GHB.[14] Eth-
anol/water (1:1, v/v) solutions of 4 show an absorption band at
l=557 nm and emission at l=574 nm. The addition of GHB
induces moderate emission quenching (2.2-fold in the pres-
ence of 10 mgmL@1 of the drug) of the band at l=574 nm.
This behavior can be ascribed to the formation of a hydrogen
bond between the phenolic hydrogen atom of the probe and
the carboxylate moiety of the drug. As a consequence of the
coordination, a photoinduced electron-transfer (PET) process is
activated, which induces the observed emission quenching.
Moreover, the authors demonstrate that probe 4 can be used
to detect GHB easily in several beverages (alcoholics, nonalco-
holics, colored, and colorless). For this purpose, 4 is dissolved
in DMSO and then mixed with the beverages spiked with
known amounts of GHB (1:1, v/v, final solution). Irradiation of
the prepared samples with a hand-held lamp (l=365 nm)
allows differences in the fluorescence intensities of GHB-free
and GHB-spiked beverages to be observed clearly by the
naked eye.
Garcia and co-workers have developed a colorimetric sensor
array for the detection of GHB.[15] The array is composed of
three columns and six rows. The first column has six tricyclic
dyes (methylene blue, thionine, oxonine, pyronine, acridine
orange, and proflavine), the second column is formed by the
same dyes complexed with cucurbit[7]ril (CB[7]), and the third
column contains the dyes complexed with cucurbit[8]ril
(CB[8]). The addition of GBH (in the 0.1–10@5m range) to the
sensor array induces remarkable color changes in some plates
due to the dethreading of CB[7] and CB[8] complexes with the
dyes after coordination of the macrocycles with the drug. The
colors obtained are ascribed to the different stability constants
for the dye–CB complexes and to the ability of GBH to disrupt
the formed supramolecular ensembles. Moreover, the chromo-
genic response of the array to GHB is quite selective, and
other possible interferents, such as GBL, 1,4-butanediol, pro-
pionic acid, butyric acid, and common salts present in water,
are unable to induce color changes.
Ma and co-workers outline the synthesis of a long-lived iri-
dium(III) chemosensor, the luminescence emission of which at
l=570 nm is quenched in the presence of GHB (Figure 2).[16]
Due to its long-lived luminescence, time-resolved emission
spectroscopy (TRES) allows the detection of GBH. A quenching
effect of 30% luminescence emission is observed 10 s after the
addition of a low concentration of GBH (0.15 mgmL@1) to a so-
lution of the complex. This quenching is clearly seen by the
naked eye under UV illumination and is not pH dependent.
Real samples of water, black tea, soda, orange juice, red wine,
Figure 1. Structures of probes 3 and 4 for the detection of GBL (1) and GHB
(2), respectively.
Figure 2. Chemical structure of iridium probe 5.
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whisky, and milk previously spiked with GHB have been evalu-
ated, which assures the suitability of this procedure for GHB
drug detection over a wide range of real-life beverages.
Al-Kaffiji and co-workers have developed a spectrophoto-
metric method for the optical detection of chlorpromazine hy-
drochloride (CPH). CPH pertains to the family of drugs com-
monly known as neuroleptic tranquilizers (used as sedatives,
antihistamines, and anesthetics) but nowadays is commonly
mixed with narcotic drugs.[17] The method is based on the reac-
tion of p-aminoacetanilide (7) with CPH in the presence of an
oxidizing agent (i.e. ferric chloride hexahydrate). This reaction
yields an intense violet product (see structure 8 in Scheme 1)
with an intense absorption band at l=590 nm. Probe 7 has
successfully been applied to the determination of CPH in aque-
ous solutions and pharmaceutical formulations with high accu-
racy and shows a linear range between 4 and 32 ppm with a
limit of detection of about 1.7 ppm.
Morris has developed a colorimetric test for ketamine hydro-
chloride on the basis of a typical cocaine detection assay by
using Co(SCN)2.
[18] Ketamine is a medication mainly used for
starting and maintaining anesthesia, but it is also a drug for
recreational purposes. Unregulated use has side effects such as
high blood pressure, abnormal heart rhythms, vomiting,
double and tunnel vision, anaphylaxis, airway obstruction, and
dependence.[19] The test consists of the basification of the sam-
ples (with sodium hydroxide) followed by the addition of
Co(SCN)2. This two-step procedure results in the formation of a
lavender to purple precipitate in the presence of ketamine,
whereas a blue to green precipitate is obtained in the absence
of ketamine. Sensibility as high as 5 mgmL@1 can be achieved,
which is good enough for the detection of this drug in com-
mercial products for medical applications (contents ranging
from 50 to 100 mgmL@1). Selectivity studies show that other
controlled substances and related chemicals yield a negative
response.
Herr#ez-Hern#ndez and co-workers follow a similar reaction
for the colorimetric sensing of ketamine by immobilizing differ-
ent amounts of the Co(SCN)2 reagent onto a polydimethylsil-
oxane (PDMS) matrix.[20] For the preparation of the materials,
the authors disperse Co(SCN)2 in an aqueous solution contain-
ing tetraethylorthosilicate (TEOS) and expose the resulting dis-
persion to PDMS to embed Co(SCN)2 in the polymer matrix.
[21]
Once the sensing material is prepared, pure ketamine detec-
tion can be performed by immersing the sensor in 0.1m NaOH
solutions of the drug. In the presence of ketamine, a purple
precipitate on the surface of the matrix polymer is formed.
However, after a few minutes, this precipitate disappears, and
the solid changes from brown to purple because of the diffu-
sion of ketamine inside the polymer and the formation of a
complex between Co(SCN)2 and the drug. The best response is
observed for a solid containing 0.3% Co(SCN)2 at l=625 nm.
A limit of detection of 100 mgmL@1 for ketamine is reported.
Besides, no interference is observed if the sensing material is
exposed to amphetamine, methamphetamine, 3,4-methylene-
dioxymethamphetamine (MDMA), cocaine, ephedrine, scopola-
mine, caffeine, acetaminophen, ibuprofen, acetylsalicylic acid,
starch, saccharose, glucose, lactose, and magnesium sulfate.
The material has been tested in real samples with fine results.
Elokely and co-workers describe the design of a new fluoro-
metric method for the detection of drugs containing cyclic a-
methylene carbonyl groups in pharmaceuticals, preparations,
and biofluids by using N-methylnicotinamide chloride (NMNCl)
as a fluorogenic reagent (Scheme 2).[22] In basic media, N-meth-
ylnicotinamide chloride forms neutral and highly reactive a-
carbinol compound 12, which reacts with drugs containing
cyclic a-methylene carbonyl groups (such as 9, 10, and 11) to
yield fluorescent derivative 15. The test is quite sensitive with
limits of detection in the 0.003–20 ngmL@1 range. The authors
also demonstrate the possible use of N-methylnicotinamide for
the detection of drugs 9, 10, and 11 in plasma samples with
nearly the same limits of detection obtained upon using water.
Elmosallamy and Amin have developed a new spectrophoto-
metric method for the detection of dextromethorphan (16)
(Figure 3) in pharmaceutical preparations.[23] The spectrophoto-
metric protocol involves the reaction between dextromethor-
phan hydrobromide with eriochrome black T (17) in acetate
buffer (pH 2.8), which results in the formation of an ion-pair
complex with an absorption band at l=520 nm. This method
for the detection of 16 is lineal in the 7.37–73.7V10@5m range
with a limit of detection of 1.29V10@5m.
Mohseni and Bahram outline the use of melamine-coated
gold nanoparticles (AuNPs) for the detection of morphine and
codeine in human serum, urine samples, and pharmaceutical
formulations.[24] The presence of melamine molecules in the
Scheme 1. Oxidation reaction with p-aminocetanilide (7) and ferric chloride
for the detection of chlorpromazine drug 6.
Scheme 2. Chemical structures of drugs 9–11 containing cyclic a-methylene
carbonyl groups, and synthetic pathway for the preparation of fluorophore
15.
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outer sphere of the AuNPs prevents aggregation, and aqueous
solutions of the nanoparticles present as a wine-red color (ab-
sorption band centered at l=675 nm). In the presence of mor-
phine and codeine, a marked color change to blue is observed
(absorbance band at l=690 nm) due to the aggregation of
the AuNPs induced by the formation of hydrogen bonds be-
tween melamine and the drugs. The proposed method exhib-
its lineal ranges of 0.07 to 3 mm for morphine and 0.03 to
0.8 mm for codeine with limits of detections of 17 and 9 nm, re-
spectively. Interference studies show that cations, anions, as-
corbic acid, glucose, urea, cysteine, glutamic acid, asparagine,
leucine, valine, proline, phenylalanine, tramadol, amphetamine,
and methamphetamine are unable to induce color modula-
tions. Besides, melamine-coated AuNPs have also been used
for the detection of morphine and codeine in biological fluids
and pharmaceutical formulations with fine results.
The probes described in this section are based on different
chemical reactions and the formation of complexes with de-
pressant drugs. Also, the analyte-induced aggregation of
AuNPs has been used to detect morphine and codeine. High
selectivity and low detection limits are achieved with most of
the probes exposed above, and thus, they are good alterna-
tives for traditional chromatographic methods. Naked-eye de-
tection, short analysis times, and no need for overqualified per-
sonnel for their daily use are some of the advantages of these
sensing probes. Besides, some probes have been tested in real
human body fluids, and thus, some of these reported exam-
ples could have potential applications for the development of
realistic systems for the detection of depressant drugs.
3. Stimulant Drugs
Stimulant drugs accelerate the activity of the central nervous
system. If high doses are taken, elevated blood-pressure levels
and increased heart and respiration rates may ensue, with the
potential risk for cardiovascular failure; however, these drugs
can also make consumers feel angry and/or paranoid.[25]
Normally, these drugs inhibit the reuptake of serotonin, nor-
epinephrine, and dopamine, which results in greater concen-
trations of these three neurotransmitters in the brain, and this
leads to multiple effects on the state of mind of the individual
user. There are a number of stimulant drugs, including those
that are legal and prescribed by doctors and those that are
considered illegal. In the group of legal drugs, caffeine and nic-
otine are the most common. On the other hand, cocaine,
crack, amphetamine, and their derivatives are found among il-
legal stimulant drugs.
Sakai and Ohno describe a procedure for the sensitive and
selective detection of methamphetamine, ephedrine, and
methylephedrine in urine (Scheme 3).[26, 27] The method consists
in the extraction of basified urine containing the drugs with
1,2-dichloroethane. Then, the organic phase, which contains
the drugs, is added to a 1,2-dichloroethane solution of tetra-
bromophenolphthalein ethyl ester (18). After a few minutes,
colored product 19 is formed. The absorption maxima are
found at l=570 nm for methamphetamine, l=555 nm for
ephedrine, and l=550 nm for methylephedrine. The proce-
dure described presents high selectivity, and calcium chloride,
sodium chloride, magnesium chloride, sodium nitrate, sodium
acetate, AlIII, FeIII, NiII, CoII, ammonium ions, urea, uric acid, crea-
tinine, and hippuric acid are all unable to induce any chromo-
genic response. In addition, the limits of detection are
3.75 mgmL@1 for methamphetamine, 4.13 mgmL@1 for ephe-
drine, and 4.48 mgmL@1 for methylephedrine.
Herr#ez-Hern#ndez and co-workers embed 1,2-naphthoqui-
none-4-sulfonate 20 (Figure 4) into polydimethylsiloxane/tet-
raethylorthosilicate/silicon dioxide
nanoparticles and use this mixture





cally.[28] Basic buffered aqueous
suspensions of the nanoparticles
show a light yellow color due to
the presence of a broad absorp-
tion band at around l=460 nm.
Upon the addition of ampheta-
mines, clear color changes to
orange (for MAMP and MDMA,
which are secondary amines) or gray-brown (for AMP and
MDA, which are primary amines) are observed. Limits of detec-
tion in the 0.002–0.005 gmL@1 range are found. The prepared
sensing material displays better selectivity for amphetamines
than for other drugs such as cocaine, cannabinol, cannabidiol,
tetrahydrocannabinol (THC), scopolamine, ephedrine, and pro-
Figure 3. Chemical structures of the drug dextromethorphan (16) and erio-
chrome black T (17).
Scheme 3. Tetrabromophenolphthalein ethyl ester 18 transformation into
red-colored product 19 in the presence of methamphetamine, ephedrine,
and methylephedrine in urine.
Figure 4. Chemical structure
of 1,2-napthoquinone-4-sulfo-
nate (20) used for the detec-
tion of amphetamine-based
drugs.
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caine. The only two drugs that interfere with amphetamine de-
tection are ephedrine and prococaine. The application of this
sensing system to real ecstasy samples allows the percentage
of amphetamine contained in the pills to be calculated. Com-
paring these results with those obtained by LC methods, no
significant differences are found.
Yagci and co-workers delineate a strategy involving the use
of a noncompetitive assay format by using a biomimetic mate-
rial, poly(phenylene)b-cyclodextrin poly(ethylene glycol) (PPP-
CD-g-PEG), to recognize cocaine due to the affinity of b-CD
toward this drug (Figure 5).[29] The authors prepare test strips
composed of a polyvinyl chloride (PVC) backing card, the
sample pad, the conjugate release pad, a nitrocellulose mem-
brane, and an absorbent pad. In the absorbent pad, there is a
conjugated pad [containing absorbed antibenzoylecgonine an-
tibody/AuNPs (Anti-BE/AuNPs)] , a control line (containing ab-
sorbed Anti-IgG antibody), and a test line (containing absorbed
PPP-CD-g-PEG). Upon applying a liquid sample without cocaine
to the sample pad and upon reaching the conjugate pad, the
Anti-BE/AuNPs migrate forward together with the liquid
sample to give a red negative line. If cocaine is present in the
sample, cocaine molecules interact with the b-CD residues in
the test line and another red line appears in the test zone as a
result of the attachment of the Anti-BE/AuNPs to cocaine. The
test results can also be analyzed by using a mobile phone ap-
plication by photographing the strips and evaluating the color
group and color percentage in the image. A good linear trend
in the 0.01–1.0 mgmL@1 range is observed. Moreover, the au-
thors find that the sensor is selective for cocaine in the pres-
ence of benzoylecgonine, nicotine, cotinine, codeine, tetrahy-
drocannabinol, and methamphetamine. Finally, the authors
demonstrate the validity of the test stripes by determining co-
caine in synthetic saliva with nearly the same accuracy as that
achieved by using chromatographic methods.
Simon’s reagent (a mixture of sodium nitroprusside, sodium
carbonate, and acetaldehyde) is a chromogenic test used for
the detection of alkaloids (containing secondary amines). The
amine moiety of the alkaloids reacts with acetaldehyde to
yield an enamine, which subsequently reacts with sodium ni-
troprusside to generate an immonium salt. Finally, this is hy-
drolyzed to a bright cobalt-blue product (known as the
Simon–Awe complex) that allows for the identification of
drugs containing secondary amines. Chooduma and co-work-
ers use this reagent to sense methamphetamine by using
mobile phone technology.[30] In their study, the samples (con-
taining methamphetamine) are kept in an opaque black corru-
gated box and are treated with Simon’s reagent; the intensity
of the colored product inside the microtube is then detected
by using the ColorAssist app (FTLapps,Inc.) for an iPhone 4.0 in
the flash-off mode. The authors relate the RGB values obtained
to the concentration of methamphetamine and then compare
the data with the gas chromatography data. The authors note
that the correlation between both sets of data, in terms of
methamphetamine concentration, is remarkable. Besides, one
year later, the same authors report the entrapment of Simon’s
reagent into a sol–gel matrix and include it in the corrugated
box.[31] For sample analysis, the solid sensor is pierced and
methamphetamine is put inside to allow the reaction between
the analyte and the reagent. The samples are then directly an-
alyzed by using the same app by studying the RGB values.
Torroba and co-workers describe the synthesis of new bis-di-
arylurea-based probe 21 (Figure 6) for the detection of MDMA
from ecstasy tablets.[32] DMSO solutions of probe 21 show a
weak emission band centered at l=517 nm upon excitation at
l=288 nm. The addition of aqueous solutions of ephedrine,
pseudoephedrine, amphetamine, 3,4-methylenedioxyampheta-
mine, and 3,4-methylenedioxymethamphetamine induces a
marked emission enhancement at l=517 nm due to the for-
mation of a 1:1 stoichiometry complex of a charge-transfer
nature. In spite of the fact that the fluorogenic response of
probe 21 toward selected drugs is unselective, principal com-
ponent analysis (PCA) score plots allow their discrimination.
Besides, MDMA has been detected in a simulated tablet of ec-
stasy. No interference is observed in the presence of excipients
(e.g. sucrose, chalk, or caffeine) in ecstasy tablets.
Cheng and co-workers give details on the preparation of
molecular probe 22 containing thiophene heterocycles and a
fluorene moiety (Figure 7) and also polymer 23 containing the
Figure 5. Schematic representation of a test stripe functionalized with PPP-
CD-g-PEG and Anti-IgG antibodies for the detection of cocaine.
Figure 6. Chemical structure of bis-diarylurea-based probe 21 for MDMA
detection.
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same functional groups for methamphetamine (MA) vapor de-
tection.[33] Films of the molecular probe and the polymer are
obtained by spin coating. The prepared films are weakly fluo-
rescent, but in the presence of MA, a marked emission en-
hancement is observed for both sensing materials. The weak
emission of the films is ascribed to a heavy-atom effect from
the sulfur atom of the thiophene to the fluorene fluorophore.
In the presence of MA, the reaction of its amino groups with
the thiophene rings of compounds 22 and 23 induces a
marked reduction in the heavy-atom effect with a subsequent
emission enhancement. Limits of detection of 1.9 and 6.4 ppm
for MA by using films containing 22 and 23 have been mea-
sured. Besides, exposure of the films to vapors of propylamine,
aniline, or toluidine induces negligible changes in the emission
intensity.
Following a similar concept, Fang and co-workers design a
perylene bisamide-containing film for methamphetamine
vapor detection.[34] Molecular probe 24 (Figure 8), containing a
perylene bisimide fluorophore and two cholesterol subunits, is
able to form self-assembly fluorescent films on a glass surface.
A broad emission band at l=678 nm is observed for the film
that is absent in the probe alone. This emission can be as-
cribed to the formation of fluorescent aggregates of the probe
within the film (through p–p interactions). This emission band
of the film is markedly quenched in the presence of metham-
phetamine vapor with a limit of detection of 5.5 ppb. Vapors
of aniline, xylidine, o-toluidine, and 1,4-diaminobenzene also
induce moderate emission quenching. Moreover, the authors
demonstrate that the film can be easily reused by purging
with cold air.
Lozano-Torres and co-workers recount the preparation of
mesoporous silica nanoparticles (MSNs) capped with pseudoro-
taxanes for the selective and sensitive fluorogenic detection of
MDMA in water (Scheme 4).[35] In a first step, the external sur-
face of the MSNs is functionalized with a naphthalene deriva-
tive, and this is followed by the encapsulation of fluorescein
inside the porous network of the inorganic scaffold. In a
second step, the loaded MSNs are capped upon the addition
of the cyclobis(paraquat-p-phenylene) hexafluorophosphate
([CBPQT][PF6]4) macrocycle, which forms inclusion complexes
with 1-naphtol subunits attached onto the external surface of
the nanoparticles. Aqueous suspensions of the nanoparticles at
pH 7.0 show negligible fluorescein release, whereas in the
presence of MDMA a marked emission band at l=520 nm
(lex=495 nm) in the solution is found. The observed emission
band can be ascribed to the release of fluorescein from the
nanoparticles due to the preferential coordination of MDMA
with the CBPQT4+ macrocycle, which results in pore opening
and cargo delivery. Besides, the prepared material is selective
to MDMA, and other common drugs (e.g. cocaine, heroin,
methadone, and morphine) are unable to induce the release of
fluorescein. A limit of detection of 4.9 mm for MDMA in water
has been determined.
He and co-workers detail the synthesis and characterization
of an amine-functionalized polyfluorene for the detection of
methamphetamine.[36] THF solutions of the prepared polyfluor-
ene show two broad emission bands at l=417 and 440 nm
(upon excitation at l=388 nm) due to the fluorene core. The
addition of methamphetamine induces a marked quenching of
the emission bands (80% upon the addition of 40 mm drug),
which can be ascribed to an aggregation process of the poly-
Figure 7. Structures of thiophene-containing fluorene derivatives 22 and 23
for MA detection.
Figure 8. Perylene bisamide based probe 24 for MA detection.
Scheme 4. Schematic representation of MDMA detection by using silica
nanoparticles and the [CBPQT][PF6]4 macrocycle.
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mer. From the emission titration profiles, a limit of detection of
25 ngmL@1 of methamphetamine hydrochloride is noted.
Other drugs such as pethidine and ephedrine also induce
marked quenching of the emission.
Prodi, Dalcanale, and co-workers report the preparation of
silica nanoparticles with pyrene derivative 25 inserted and
with a hydrophilic external surface due to the presence of a
poly(ethylene glycol) shell for MDMA detection in water
(Figure 9).[37] Aqueous suspensions of the prepared nanoparti-
cles present the typical monomer/excimer emission spectrum
of the pyrene fluorophore with bands at about l=395 and
475 nm. Upon the incorporation of cavitand 25 into the hydro-
phobic compartment of the nanoparticles, both pyrene units
are in close spatial proximity, which allows the formation of an
excimer (band centered at l=475 nm). The addition of in-
creasing quantities of MDMA induces progressive and marked
quenching of only the excimer band. The authors ascribe this
fact to the inclusion of the amine moiety of MDMA into the
cavitand, which induces spatial separation of both pyrene fluo-
rophores and disrupts initial excimer 26. The addition of 3-fluo-
romethamphetamine (FMA) also induces excimer emission
quenching but to a lesser extent than that observed for
MDMA. Amphetamine, glucose, glycine, and sarcosine are
unable to induce any emission change.
Garc&a-EspaÇa and co-workers report the synthesis of macro-
cyclic probes 27 and 28 (Figure 10) containing fluorene and
naphthalene fluorophores and their sensing behaviors towards
amphetamine sulfate (AMPH), methamphetamine hydrochlo-
ride (METH), 3,4-methylenedioxymethamphetamine hydrochlo-
ride (MDMA), and dopamine (DA).[38] A water/methanol (7:3,
v/v, pH 7.4) solution of probe 27 shows typical fluorene emis-
sion bands at l=377, 396, and 416 nm. The addition of AMPH,
METH, MDMA, and DA to a solution of 27 induces a marked
emission enhancement that is nearly of the same order for the
four drugs and ascribed to the formation of 1:1 adducts. In
contrast, more selective behavior is found with naphthalene-
bearing probe 28. In this case, a water/methanol (7:3, v/v,
pH 7.4) solution of 28 shows the typical naphthalene emission
band that is enhanced only upon the addition of MDMA and
DA.
Ishii and co-workers present an optimized version of a previ-
ously published method[39] for the detection of MDMA, MDA,
and related drugs that consists in a rapid colorimetric reaction
with chromotropic acid (CTA) in 75% (w/v) aqueous sulfuric
acid at room temperature (Scheme 5).[40] In this protocol, form-
aldehyde (33) is generated by treating MDMA with sulfuric
acid. Then, formaldehyde induces the coupling of two CTA
molecules to yield red-violet product 34 that can be examined
visually or by measuring its absorbance at l=570 nm. The
band at l=570 nm gradually increases with an increase in the
drug concentration. The optimal concentration of CTA and the
optimal reaction time are 1.0 mm and 30 min, respectively,
whereas the drug concentration should not be greater than
100 mm to avoid nonspecific color development. Finally, seized
tablets containing well-known concentrations of both MDMA
and MDA have been processed and analyzed by using the pro-
posed methodology.
Haghgoo and Rouhani describe the synthesis of 1,8-naphtali-
mide–thiophene derivative 35, which is further attached to
silica nanoparticles to give 35@SiO2.
[41] Toluene solutions of 35
present a broad emission band centered at l=435 nm, which
shifts to l=473.5 nm if grafted onto silica nanoparticles. The
addition of methamphetamine to a solution of probe 35
(Figure 11) or to a suspension of the nanoparticles (using tolu-
ene in both cases) induces marked emission enhancements
(7.3 and 15.4-fold for free 35 and 35@SiO2, respectively). These
emission enhancements can be ascribed to inhibition of the
heavy-atom effect (from the thiophene ring) upon coordina-
tion of the probes with methamphetamine. In contrast, negligi-
Figure 9. Schematic representation of MDMA detection by interaction with
pyrene derivative 25.
Figure 10. Chemical structures of macrocyclic probes 27 and 28 for the de-
tection of drugs 29, 30, and 31.
Scheme 5. MDMA detection through the generation of formaldehyde.
Formed formaldehyde reacts with CTA to yield red-violet product 34.
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ble fluorescence changes are observed for other amines such
as o-toluidine, hexylamine, diethylamine, dibutylamine, allyl-
amine, and trimethylamine, whereas slight quenching is found
for aniline. Furthermore, methamphetamine vapor sensitivity
has successfully been evaluated by exposing analyte-saturated
vapors (6.7 mmolL@1 to 0.27 mmolL@1 concentration) over
35@SiO2 on glass, which shows reversibility after vapor remov-
al. Finally, the proposed probe has been validated with HPLC,
and there is satisfactory agreement between the results ob-
tained with both methods.
Maue and Schrader outline the design and synthesis of a
new family of catecholamine probes (i.e. compounds 36–38)
combining bisphosphonate recognition moieties (for amino al-
cohols) and boronic acid groups (for the recognition of cate-
chols) in one chemical structure.[42] The addition of alizarine
red-S to aqueous solutions of the three probes induces a
marked color change from deep red (free dye with an absorb-
ance band at l&520 nm) to orange (band centered at l=
460 nm) due to the formation of 1:1 complexes (Figure 12). In
the presence of noradrenaline, a marked decrease in the band
at l=460 nm is observed together with an increase in the ab-
sorbance at l=520 nm (color change from orange to deep
red). These changes in color can be ascribed to preferential co-
ordination of noradrenaline with the probes that displace ali-
zarine red-S from the sensing ensemble to the solution. Several
potential interferents have been examined, and no positive re-
sponse for simple biogenic amines (creatinine), sugars (e.g.
glucosamine, glucose, fructose, saccharose), neurotransmitters
(e.g. g-aminobutyric acid, serotonin, acetylcholine), and amino
acids (e.g. serine, phenylalanine, alanine, histidine, lysine, tryp-
tophan, glycine) is observed.
Basavaiah and co-workers design a spectrophotometric
method for the determination of six phenothiazine drugs (i.e.
chlorpromazine hydrochloride, promethazine hydrochloride,
trifluoromazine hydrochloride, trifluoperazine hydrochloride,
thioproperazine mesylate, and prochlorperazine mesylate) in
pharmaceutical preparations.[43] This method is based on the
oxidation of the drugs in sulfuric acid medium by a known
excess amount of chloramine-T. Then, the excess amount of
chloramine-T reacts with 4-N-methylaminophenol in the pres-
ence of an aromatic amine to produce a purple-red product
with an absorption maximum at l=520 nm.
Inwang and Mosnaim report the development of an efficient
and specific extraction procedure for the UV spectrophotomet-
ric detection of 2-phenylethylamine (PEA) through reaction
with ceric sulfate (CeSO4) to form a fluorescent probe.
[44] Sam-
ples are treated with CeSO4 and HCl in n-hexane, and this is
followed by filtration and extraction of the aqueous layer. This
procedure has also been evaluated for biological samples, in
addition to real human, cat, and rabbit organs as well as urine.
A linear relationship is found between the concentration of
PEA and the UV absorbance at l=287 nm, with a limit of de-
tection of 0.1 mgmL@1.
Wang and co-workers discuss the development of two fluo-
rescence chiral sensors for the enantiomeric recognition of d-
and l-a-phenylethylamines (Figure 13).[45] The author prepared
Figure 11. MA detection process with functionalized nanoparticles 35@SiO2.
Figure 12. Chemical structures of catecholamine probes 36–38 and recogni-
tion mechanism. Alizarine red-S is displaced in the presence of noradrenaline
due to higher affinity with the probe.
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dimeric and oligomeric binaphthol derivatives 39 and 40, re-
spectively, for detection through a host–guest interaction be-
tween 39 or 40 with the chiral amines. It is suspected that the
chiral amines interact with the host through p–p interactions
between the naphthyl moieties and the amino phenyl group.
These interactions produce changes in the emission intensity
of the probes depending on the concentration of the guest
molecule. As most amines do not have chromophores, the typ-
ical emission at l=410 nm for the naphthalene ring of the
host structures can be used to follow changes in the fluores-
cence intensity. With the addition of different concentrations
of the chiral guest phenylethylamines, the fluorescence quan-
tum yield of the solutions can be measured, and fluorescence
emission reversion behavior is observed. The fluorescence re-
sponses of these two developed chiral sensors are influenced
by the concentration of the target chiral amines. The recogni-
tion can be confirmed by 1H NMR spectroscopy measurements.
El-Didamony and Gouda report on the development of a
spectrofluorometric method for the detection of pseudoephe-
drine (41) in commercial pharmaceutical formulations in pure
and dosage forms through its derivatization with 4-chloro-7-ni-
trobenzofurazan (42) (Scheme 6).[46] Compound 42 itself is non-
emissive but upon reaction with thiols or amines, it forms
highly fluorescent product 43. In phosphate-buffered saline
(PBS, pH 7.8), 41 reacts with 42 to yield a strongly emissive de-
rivative with a band at l=532 nm. The authors optimize sever-
al parameters such as pH, buffer, concentration, solvent, and
temperature finally to propose a method that can measure
concentrations of 41 down to 0.5 mgmL@1 with good accuracy
and precision.
Poryvkina and co-workers validate a new procedure for the
detection of several common street drugs such as cocaine,
MDMA/MDA, and heroine/morphine on the basis of spectral
fluorescence signature (SFS) measurements and artificial
neuron networks (ANNs).[47] SFS analyses generate a two-di-
mensional spectra matrix for which the intensity depends on
the excitation/emission wavelengths and the concentration of
the analyte. For cocaine detection, the fluorescence emission
intensity at l=315 nm can be evaluated (lex=235 and
273 nm) with an enhancement and quenching in the presence
of cocaine salt. On the other hand, the MDMA fluorescence
emission intensity at l=320 nm (lex=235 and 285 nm) is en-
hanced if the drug is present. To differentiate MDMA from
MDA, the samples can be treated with o-phthalaldehyde-N-
acetylcysteine (OPA-NEC), which forms selectively an isoindole
complex with MDA with a maximum emission at l=425 nm
(lex=335 nm). On the other hand, heroin analysis is based on
the detection of morphine in the sample due to the great simi-
larity of their corresponding structures. The fluorescence of
heroin in water is not strong enough to confirm the presence
of heroin in multicomponent samples, but the presence of
morphine can be detected because of its high quantum yield
of fluorescence. For this purpose, samples are treated with hy-
drochloric acid to convert morphine into the morphine salt.
Growth of the fluorescence signal is observed at l=345 nm
(lex=285 nm) after treatment. The designed protocol shows
excellent selectivity and limits of detection. Besides, 98.7% of
samples are correctly identified, assuring the robustness of the
method. Due to the great amount of data generated, the use
of ANN as a tool for pattern recognition of SFS is required,
which includes a learning step and posterior validation.
One of the most extensive strategies for the fluorogenic and
chromogenic detection of drugs is based on aptasensors,
which are a class of biosensor systems based on the use of
DNA or RNA aptamers as recognition sites. Aptamers can rec-
ognize selectively certain target molecules through the forma-
tion of a specific three-dimensional site obtained due to nu-
cleotide chain folding.[48] Aptasensors usually show very high
sensitivity, specificity, and reproducibility against a wide variety
of targets.
As an alternative to traditional chemosensors for metham-
phetamine (MA) detection, Shi and co-workers present a
simple colorimetric assay for the sensitive and visual detection
of this drug in both aqueous solution and human urine.[49] The
proposed strategy comprises the advantages of using a selec-
tive methamphetamine aptamer (as the recognition element)
and unmodified easy-to-prepare AuNPs (as an indicator). In a
first step, citrate-coated AuNPs are prepared, and then, the co-
caine aptamer is adsorbed onto the external surface of the
nanoparticles. An aqueous solution of the aptamer-coated
AuNPs shows the characteristic plasmon absorption band at
l=525 nm (red color), which is indicative of the presence of
nonaggregated individual nanoparticles. The addition of in-
creasing amounts of methamphetamine induces the progres-
sive appearance of an absorption band centered at l=660 nm
with a subsequent color change from red to blue. This change
in color can be ascribed to coordination of methamphetamine
Figure 13. Chemical structures of fluorescent dimeric and oligomeric probes
39 and 40 for l-a-phenylethylamines.
Scheme 6. Detection of 41 by derivatization with 4-cloro-7-nitrobenzofura-
zan (42). The reaction results in the formation of fluorescent adduct 4.
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with the coating aptamer, which induces aggregation of the
AuNPs (Figure 14). Using a calibration curve, the reported apta-
sensor is able to detect methamphetamine in aqueous solu-
tions at concentrations ranging from 2 to 10 mm with a limit of
detection of 0.82 mm. The aptasensor is also able to detect
methamphetamine in urine with recoveries ranging from 96.0
to 107.0% and with high selectivity against potential compet-
ing alkaloids such as pethidine, triazolam, barbital, morphine,
ketamine, and diazepam.
Li et al. outline the construction of a colorimetric metham-
phetamine probe consisting of a G-quadruplex–hemin DNA-
zyme molecular beacon, a drug aptamer, and a colorimetric
substrate (Figure 15).[50] In the presence of methamphetamine,
the DNAzyme dissociates because of strong interactions be-
tween the drug and its aptamer, and this results in the forma-
tion of a G-quadruplex–hemin complex with peroxidase activi-
ty that catalyzes the oxidation reaction of 2,2’-azinobis(3-ethyl-
benzothiozoline)-6-sulfonic acid to yield a light-green deriva-
tive with an absorbance band at l=415 nm. The proposed
aptamer-based probe shows excellent linearity with the meth-
amphetamine concentration and a limit of detection of 0.5 nm.
The selectivity with 15 other illicit drugs or metabolites (i.e.
ketamine, norketamine, morphine, methadone, cocaine, meph-
edrone, cathinone, methcathinone, 3-trifluromethylphenyl pi-
perazine, 1-(3-trifluromethylphenyl)piperazine, 3,4-methylene-
dioxypyrovalerona, MDA, MDMA, 2-ethylidene-1,5-dimethyl-
3,3-diphenylpyrrolidine, and meta-chlorophenylpiperazine) has
been evaluated, yet none of them show a significant UV/Vis
response.
Willner and co-workers report the design of an aptamer-
based nanomachine for the fluorogenic detection of cocaine.[51]
The nanomachine contains three regions: 1) a cocaine apta-
mer; 2) a nicking site for endonuclease (Nt.BbvCI) ; 3) a trans-
duction region (Figure 16). Initially, the aptamer recognizes the
cocaine molecule, and then, in the presence of polymerase
and 2’-deoxynucleosidetriphosphates (dNPTs), the complemen-
tary strand is synthesized (see Figure 16b). Then, region 2 is
nicked by Nt.BbvCI endonuclease, and this is followed by a
cyclic process by which the complementary region is repeated-
ly polymerized with the aid of the polymerase enzyme. The re-
leased transduction region (see Figure 16d) hybridizes with its
complementary strand, which separates the two fluorophores
(i.e. carboxyfluorescein and 5-carboxytetramethylrhodamine)
and forbids the fluorescence resonance energy transfer (FRET)
process to which they were submitted. Finally, a limit of detec-
tion of 5V10@6m for cocaine can be achieved.
The same authors have also created an amplified aptamer
sensor for cocaine (Figure 17).[52] The developed system is
formed by three domains: 1) a domain that corresponds to the
cocaine aptamer, which is blocked by the complementary
strand; 2) a domain containing a nicking strand; 3) the trans-
duction region. In presence of cocaine, the system begins the
replication and nicking processes ; this releases domain 3,
which is complementary to the strand containing a fluoro-
phore and a quencher (off state). Then, the DNAzyme cleaves
the fluorophore/quencher to yield the fluorophore-labeled
strand (separated from the quencher) that provides the read-
out signal for the analysis of cocaine (on state). The limit of de-
tection for cocaine is 0.1 mm. Finally, a method for amplified
cocaine detection has been developed by the coupling of a
second replication/nicking system that includes an autono-
Figure 14. Schematic representation of MA colorimetric detection consisting
in the preferential interaction of the aptamer with the drug rather than with
AuNPs.
Figure 15. Colorimetric methamphetamine aptasensor based on the perox-
idase activity of the formed G-quadruplex–hemin complex resulting in the
oxidation of 2,2’-azinobis(3-ethylbenzothiozoline)-6-sulfonic acid to a light-
green-colored derivative. ssDNA= single-stranded DNA.
Figure 16. Fluorogenic aptasensor for the detection of cocaine: a) cocaine
recognition, b) complementary strand synthesis, c) nicking with Nt.Bbv.Cl fol-
lowed by polymerization, and d) hybridization of the synthesized strand
with fluorescent conjugated hairpin structure that avoids the FRET process
and allows carboxyfluorescein emission.
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mous self-replication process. The limit of detection for the
amplified system is 1V10@18m ; this is roughly 104-fold more
sensitive than other DNA-sensing platforms.
Wang and co-workers validate the use of a fluorescence
label-free aptasensor for detecting cocaine in complex bio-
fluids.[53] The system consists of an aptamer and two fluoro-
phores, 2-amino-5,6,7-trimethyl-1,8-naphthyridine (ATMND)
and SYBR Green I (SGI), which serve as a signal reporter and a
built-in reference, respectively. Both fluorophores interact
strongly with the aptamer, and as a consequence, their fluores-
cence is quenched. However, if cocaine is added, an enhance-
ment in the fluorescence emission of ATMND is observed. This
emission enhancement can be ascribed to the fact that
ATMND coordinates with the binding cavity of the aptamer
and is displaced in the presence of cocaine. The authors report
a limit of detection of 56 nm. The system has been tested in bi-
ofluids (e.g. saliva, serum, and urine) with fine results.
Huang and co-workers detail the design of a new system
based on a strand-displacement polymerization reaction by
using aptamer recognition for the detection of cocaine
(Figure 18).[54] The system consists of a hairpin probe labeled
with Cy5 (acceptor fluorophore) on its 3’-end and containing
the cocaine aptamer sequence, a primer derivatized on its 5’-
end with carboxy fluorescein (a donor fluorophore), and a
polymerase (which induces DNA sequence synthesis). If co-
caine is present, the hairpin probe recognizes the drug and
the polymerase induces DNA synthesis ; this results in proximi-
ty between the donor and acceptor fluorophore, which leads
to a fluorescence enhancement. The limit of detection for co-
caine is 20 nm. Finally, the authors also evaluate the systems in
the presence of benzoylecgonine and ecgonine methyl ester.
Neither of the tested interferents induce emission changes.
Johnson and co-workers discuss the development of an ap-
tameric cocaine sensor based on FRET between quantum dots
(QDs) and the fluorophore Cy5 (Figure 19).[55] For this purpose,
QDs coated with streptavidin are functionalized with the
single-stranded DNA sequence 5’-TCA CAG ATG AGT-biotin-3’.
Then, the cocaine aptamer is sandwiched between this oligo-
mer and 5’-GTC TCC CGA GAT-Cy5-3’. Upon excitation of the
QDs at l=605 nm in an aqueous suspension of the sensor, the
typical emission band of the Cy5 fluorophore at l&675 nm
appears due to the presence of a FRET process between the
nanoparticles and the fluorophore. However, in the presence
of cocaine, the random-coil aptamer changes to a hairpin con-
formation, which releases the Cy5 fluorophore brand with sub-
sequent suppression of the FRET process. As a consequence,
the emission of Cy5 is progressively quenched depending on
the amount of cocaine added. The limit of detection for co-
caine is 0.5 mm, as determined by a titration profile. Besides,
the authors modify the probe to obtain an emission enhance-
ment as output. For this purpose, they include a Cy5 quencher
into the probe structure. The surface of the QDs is functional-
ized with 5’-Cy5-TCA CAG ATG AGT-biotin-3’. The cocaine apta-
mer is again sandwiched between this oligomer and 5’-GTC
TCC CGA GAT-Iowa Black RQ-3’ containing a quencher of Cy5.
The presence of the quencher inhibits the FRET process be-
tween the QDs and Cy5. In the presence of cocaine, the
quencher oligomer is released due to a change in the aptamer
to the hairpin conformation and the FRET process occurs with
a subsequent turn-on response. The limit of detection for co-
caine is 0.5 mm, as determined by a titration profile.
Abnous and co-workers merge two different types of nano-
particles to construct an aptasensor for the fluorogenic detec-
tion of cocaine.[56] The authors first prepared silica nanoparti-
cles coated with streptavidin and functionalized with 5’-fluo-
rescein-ATT GAA GGA TTT ATC CTT GTC TCC CTA TGC TTC AAT-
biotin-3’ (complementary sequence to that of the cocaine
Figure 17. Schematic representation of the cocaine aptasensors.
Figure 19. Cocaine aptasensor operating scheme. In the presence of co-
caine, the aptamer changes to a hairpin conformation and avoids the FRET
process and suppresses Cy5 emission. CQDs= carbon quantum dots.
Figure 18. Schematic representation of a cocaine aptasensor based on the
actuation of polymerase and interaction of two fluorophores in the presence
of the drug.
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aptamer). On the other hand, they also prepare AuNPs func-
tionalized with the 5’-CCA TAG GGA GAC AAG GAT AAA TCC
TTC AAT GAA GTG GGT CTC CC-thiol-3’ sequence containing
the cocaine aptamer. Upon mixing both nanoparticles, the
complementary strands hybridize, and the emission of fluores-
cein is quenched because the fluorophore is in close proximity
to the AuNPs. The addition of cocaine induces dehybridization
of the double-stranded DNA fragment due to drug–aptamer
coordination. This process detaches both types of nanoparti-
cles, and as a consequence, fluorescein emission is restored.
Besides, the limits of detection of cocaine in water (209 pm)
and serum (293 pm) have been determined. The authors find
that chloramphenicol, propranolol, and diazepam are unable
to induce any emission enhancement, whereas morphine
yields the same response as cocaine.
Xiao et al. report a label-free aptamer–fluorophore ensemble
to detect cocaine.[57] The authors observe that the typical apta-
mer used to recognize cocaine is
able to complex the fluorophore 2-
amino-5,6,7-trimethyl-1,8-naphthyr-
idine (44) (Figure 20). Due to com-
plexation, fluorescence of 44 is
quenched. However, in the pres-
ence of cocaine, the complex be-
tween the aptamer and the fluoro-
phore is disrupted, and an emis-
sion enhancement is observed.
The authors note a limit of detec-
tion of 200 nm in water. Besides,
the sensing ensemble allows the selective detection of cocaine
in the presence of its metabolite benzoylecgonine. In urine
and saliva, the aptasensor presents limits of detection of 460
and 520 nm, respectively.
Coskunol et al. create an aptamer-folding-based sensing
device for cocaine detection.[58] Poly-l-lysine-coated microwells
are used as inorganic supports and QDs functionalized with
carboxylic acid groups are grafted onto the surface by using
N-hydroxysuccinimide (NHS)/1-ethyl-3-(3-dimethylaminopro-
pyl)carbodiimide (EDC). On the other hand, AuNPs functional-
ized with the cocaine aptamer sequence 5’-NH2-C6-AGA CAA
GGA AAA TCC TTC AAT GAA GTG GGT CG-C3-SH-3’ are anch-
ored to the QDs also by using NHS/EDC. In the absence of co-
caine, strong fluorescence from the QDs is observed, whereas
in the presence of the drug, this emission is quenched
(Figure 21). This emission quenching can be ascribed to coordi-
nation of the aptamer to cocaine, which brings the QDs close
to the AuNPs with subsequent fluorescence deactivation. The
same response is observed for benzoylecgonine. The limits of
detection for cocaine and its metabolite are 0.138 nm and
1.66 mm, respectively. The aptasystem is selective for cocaine
and benzoylecgonine in the presence of methamphetamine, 3-
acetamidophenol, and codeine. Finally, upon analyzing syn-
thetic urine samples containing cocaine and benzoylecgonine
with the sensing material and comparing the results with
those obtained by traditional HPLC methods, no significant dif-
ferences are found.
Mart&nez-M#Çez and co-workers implement “molecular
gates” onto nanoporous anodic alumina (NAA) to prepare a
sensing material for cocaine detection (Figure 22).[59] The NAA
support, obtained according to reported procedures,[60] is
loaded with rhodamine B and functionalized with (3-isocyana-
topropyl)triethoxysilane. Then, the amino-terminal DNA se-
quence NH2-(CH2)6-5’-AAA AAA CCC CCC-3’ is covalently linked
to the surface by the formation of urea bonds. In a final step,
the pores are capped with the 5’-TTT TGG GGG GGG GAG ACA
AGG AAA ATC CTT CAA TGA AGT GGG TCT CCA GGG GGG TTT
T-3’ sequence, which specifically hybridizes with the short DNA
fragment attached to the external surface of NAA and contains
the cocaine aptamer. If the sensing material is immersed in Tris
solution (pH 7.5) without cocaine, negligible dye release is ob-
served. However, in the presence of the drug, marked rhoda-
mine B delivery is found (reaching 100% after 50 min). Using a
calibration curve obtained upon adding increasing amounts of
cocaine, a limit of detection of 5.0V10@7m is calculated. Be-
sides, the material presents good selectivity for cocaine, and
no response is observed by exposing it to other drugs such as
morphine and heroine. Finally, the sensor has been validated
in saliva. The same research group has developed a homolo-
gous nanostructured system for the detection of cocaine by
surface-enhanced Raman spectroscopy (SERS).[61]
Landry and co-workers outline the development of a cocaine
sensor based on the assembly of fluorophore-labeled heterodi-
meric aptamers in the presence of the analyte.[62] The authors
prepare two oligonucleotides containing the cocaine aptamer
Figure 20. Structure of 2-
amino-5,6,7-trimethyl-1,8-
naphthyridine (44).
Figure 21. Schematic illustration for cocaine detection by using an aptamer
and AuNPs.
Figure 22. Schematic representation for cocaine detection by using silica
nanoparticles with a fluorescent dye encapsulated and an aptamer as molec-
ular gates.
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sequence. One of the oligonucleotides is labeled with a 5’-car-
boxyfluorescein fluorophore, whereas the other is functional-
ized with the well-known fluorescence quencher dabcyl at the
3’-position. In the presence of cocaine in a buffered solution
and with optimal oligonucleotide chain concentration, hetero-
dimerization of both aptameric sequences results in fluorescein
emission quenching at l=518 nm (Figure 23). This sensor has
a limit of detection of 1 mm and has excellent selectivity, as no
quenching effect is observed in the presence of the cocaine
metabolites benzoylecgonine and ecgonine methyl ester.
The same authors have also engineered a new method for
the detection of cocaine in serum by using a deoxyribonucleo-
tide-based aptamer (Figure 24).[63] The proposed method con-
sists of an aptamer that is designed taking into account that
binding with cocaine induces a marked change in its secon-
dary structure and, as a consequence, in the emission of a
grafted fluorophore. The authors construct a double-labeled
aptamer with 5’-fluorescein as the fluorophore and 3’-dabcyl
as the quencher. In the absence of cocaine, both the fluores-
cein and quencher are far away, and excitation of the fluoro-
phore results in its emission at l=518 nm. However, in the
presence of cocaine, the aptamer changes its conformation
upon coordination with the drug, and thus, the fluorophore
and quencher come into close proximity. As a consequence,
the emission of fluorescein is quenched. The aptamer allows
the detection of cocaine in the 10 mm to 2.5 mm range. Finally,
the authors demonstrate that the sensor is highly selective for
cocaine and is useful for the screening of cocaine hydrolases.
In 2002, Landry and Stojanovic developed another cocaine
sensor that consists in the displacement of a cyanine dye from
the hydrophobic pocket generated by anticocaine aptamer
MNS-4.1 upon binding with the drug (Figure 25).[64] The au-
thors screen 35 different dyes to find one that displays both
significant attenuation of absorbance and a change in the ratio
of two relative maxima. Thus, the authors select diethylthiotri-
carbocyanide dye and mix it with the aptamer MNS-4.1 in a
buffered media. Then, increasing concentrations (2 to 600 mm)
of cocaine are added, and a decrease in the absorption at l=
760 nm is observed (whereas the absorption band at l=
670 nm remains unaltered). Negligible changes in the visible
spectra are found upon adding the cocaine metabolites ben-
zoylecgonine and ecgonine methyl ester (up to 2 mm). Finally,
marked color changes (from colorless to blue) are observed
upon using higher dye and aptamer concentrations (40 and
20 mm, respectively) in the presence of 500 mm cocaine.
Recently, Liu and Zhao presented an aptasensor labeled on
a specific position at one G base with the tetramethylrhoda-
mine (TMR) fluorophore that is able to detect cocaine in aque-
ous environments.[65] In the absence of cocaine, the labeled
aptamer adopts a conformation in which TMR interacts with
the surrounding guanine nucleotides. As a consequence of
these interactions, TMR suffers from restricted freedom, which
is reflected in high fluorescence anisotropy (unequal intensities
along different axes of polarization). However, upon binding of
cocaine to the aptasensor there is a change in the conforma-
tion and also an alteration in the TMR–guanine interactions,
which is reflected by a decrease in the fluorescence anisotropy
(Figure 26). The best fluorescence anisotropy changes are ob-
tained in the pH range of 7.0 to 8.5 at 10 8C. Moreover, the pre-
sented aptasensor allows the direct detection of cocaine with
a limit of detection of 5 mm and also enables the detection of
Figure 23. Conformational change in the aptamer in the presence of cocaine
and subsequent fluorescent emission quenching.
Figure 24. Conformational change in the aptamer in the presence of cocaine
and subsequent fluorescent emission quenching.
Figure 25. Displacement of cyanine dye from the hydrophobic pocket gen-
erated by the anticocaine aptamer if the cocaine drug is present.
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the drug spiked in diluted serum and urine samples. The
system has also been tested against theophylline, caffeine,
bovine serum albumin, immunoglobulin G, and a few amino
acids, including arginine, phenylalanine, and aspartic acid. No
remarkable fluorescence changes are observed, even at high
concentrations.
Dong and co-workers delineate the development of a
simple and easy to prepare colorimetric aptasensor for cocaine
detection in aqueous solutions.[66] Double-stranded (ds) DNA
can act as an efficient template for the formation of highly
emissive copper nanoparticles (CuNPs) by using low concentra-
tions of CuSO4. However, the ssDNA template does not sup-
port the formation of CuNPs. The design consists of the use of
two ssDNA sequences, one of them the cocaine aptamer and
the other its complementary counterpart. Both sequences hy-
bridize to form dsDNA, which acts as a template for the forma-
tion of fluorescent CuNPs in the presence of CuSO4. However,
in the presence of cocaine, the dsDNA dehybridizes due to the
selective binding of the aptamer sequence with the drug,
which precludes the formation of the emissive CuNPs
(Figure 27). Other analgesic drugs (e.g. pethidine and metha-
done) and the complete hydrolysate form of cocaine (ecgo-
nine) induce negligible responses. Besides, this aptasensor
shows a good linear relationship in the presence of cocaine
with a limit of detection of 0.1 mm.
Li’s group outlines the development of a system for the de-
tection of cocaine by employing a cocaine aptamer as a recog-
nition site, graphene oxide (GO) as the fluorophore, and gold
nanoparticles (AuNPs) as the quencher.[67] The cocaine aptamer
is divided into two different fragments, C1 and C2, that are co-
valently immobilized onto GO and the AuNPs, respectively. In
the presence of cocaine, aptamers C1 and C2 hybridize. This
induces spatial proximity between the AuNPs and GO with
subsequent emission quenching of the latter (Figure 28). With
this simple aptasensor, the limit of detection for cocaine is
0.1 mm. The system works well in biological fluids such as
plasma and serum. Moreover, the authors find that 0.1 mm co-
caine leads to fluorescence quenching, whereas no effect is
observed in the case of pethidine and methadone, even at
concentrations as high as 50 mm (500 times the concentration
of cocaine).
A similar GO-based aptasensor for cocaine detection by
using cocaine-selective aptamers is also reported by Zhang
and co-workers (Figure 29).[68]
Fan and co-workers present a bioassay strategy to detect co-
caine on the basis of AuNPs and modified DNA aptamers.[69] In
this design, the cocaine aptamer is divided into two pieces
that present random-coil-like conformations (ACA-1 and ACA-
Figure 26. Schematic representation of the conformational change in the co-
caine aptasensor that diminishes fluorescence emission of the TMR fluoro-
phore attached to a G base in the presence of cocaine.
Figure 27. Schematic illustration for cocaine detection through aptamer con-
formational change.
Figure 28. Schematic representation for cocaine detection through aptasen-
sors based on graphene oxide and gold nanoparticles.
Figure 29. Schematic representation for the cocaine-sensing mechanism. In
the presence of cocaine, the aptamer adopts a hairpin conformation and
joins a complementary strand containing a fluorescein dye, which is released
by enzyme Exo-III.
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2). In the absence of cocaine, ACA-1 and ACA-2 spontaneously
bind with the AuNPs, which stabilizes the AuNPs and precludes
them from undergoing aggregation. Consequently, the typical
plasmon band centered at l=520 nm and a dark red color are
observed. However, in the presence of cocaine, the solution
turns blue (absorption band at l=650 nm) due to the forma-
tion of a tertiary structure between ACA-1, ACA-2, and the
drug, and this results in aggregation of the AuNPs (Figure 30).
Using this strategy, cocaine in the low-micromolar range can
be selectively detected by the naked eye. The limit of detec-
tion for cocaine is as low as 2 mm.
Liu and co-workers report a similar aptasensor for cocaine
detection by using aptamers previously immobilized on the
surface of AuNPs (Figure 31).[70]
Zou and co-workers also use the combination of AuNPs and
a triple-fragment aptamer for the selective optical detection of
cocaine.[71] In the absence of cocaine, the three aptamer frag-
ments interact with the AuNPs, which prevents their aggrega-
tion, and as a consequence, the solution remains red. In the
presence of cocaine, the three aptamer fragments bind with
the drug, leaving the AuNPs to form aggregates (Figure 32)
with a color change to blue. The system is selective to cocaine,
and no response is found in the presence of ecogonine methyl
ester and benzoylecgonine. This aptasensor shows a gradual
color change from red to blue as the concentration of cocaine
is increased from 0 to 200 mm. A concentration of 100 mm co-
caine in human urine or serum is readily detected by using
this protocol.
Zhang and co-workers discuss a label-free fluorescence apta-
sensor for cocaine detection on the basis of the high affinity of
a G-quadruplex for the ruthenium polypyridyl complex Ru-
[(bpy)2(bqdppz)]
2+ (bpy=2,2’-bipyridine, bqdppz = benzo[j]-
quinoxalino[2,3-h]dipyrido[3,2-a:2’,3’-c]-phenazine).[72] The au-
thors modify a cocaine-selective aptamer by extending the
original sequence with guanine bases, which can form an in-
termolecular G-quadruplex under certain experimental condi-
tions. The authors note that the Ru complex can be successful-
ly embedded into the G-quadruplex structure to increase the
fluorescence. However, in the presence of cocaine, the drug
binds selectively to the aptamer, which results in dissociation
of the G-quadruplex and release of Ru[(bpy)2(bqdppz)]
2+ ac-
companied by significant emission quenching (Figure 33). The
fluorescence intensity at l=600 nm decreases upon increasing
the concentration of cocaine from 12 to 1300 nm, and the de-
tection limit is as low as 5 nm. This system is highly selective
towards cocaine over other small drugs such as caffeine, mor-
phine, and theophylline. Furthermore, detection of cocaine in
human serum can be performed with recoveries in the 94.5–
103.6% range.
An example using modified aptamers grafted onto an opti-
cal fiber biosensing platform for the detection of cocaine is re-
ported by He’s group.[73] In this work, a cocaine aptamer is split
into two fragments, and one of them is modified with a fluoro-
Figure 30. Cocaine detection by using aptamers ACA-1 and ACA-2. In the
presence of cocaine, aptamers ACA-1 and ACA-2 adopt a coil-like conforma-
tion, allowing AuNP aggregation and a color change.
Figure 32. Three fragments of the cocaine aptamer are assembled in the
presence of the drug, allowing AuNP aggregation and a color change.
Figure 31. Cocaine aptamer anchored onto magnetic microbead surface.
The aptamer changes its conformation in the presence of cocaine, releasing
ssDNA and allowing chemiluminescence detection of the drug. HRP= horse-
radish peroxidase, p-1P= p-iodophenol, CL= chemiluminescence.
Figure 33. The intramolecular complex formed between the G-quadruplex
and Ru[(bpy)2(bqdppz)]
2+ is disassembled in the presence of cocaine, allow-
ing its detection by emission quenching.
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phore (Cy3) and the other with a quencher (BHQ = black hole
quencher). In addition, the fluorophore-containing aptamer
fragment is extended by 13 bases that can hybridize with an
oligonucleotide previously immobilized on the optical fiber
platform. In the presence of cocaine, the two fragments quick-
ly form a three-way junction around the drug, which positions
the fluorophore and the quencher in close proximity with sub-
sequent emission quenching (Figure 34). At the same time, the
tail of the three-way junction hybridizes with the oligonucleo-
tide sequences immobilized on the optical fiber surface, and
changes in the fluorescence are controlled by an evanescent
wave. The aptasensor displays a highly competitive limit of de-
tection of 165 nm and a sensing concentration range between
200 nm and 200 mm. The selectivity of this aptasensor has also
been investigated against several compounds, including kana-
mycin, amikacin, and ibuprofen. No signal changes are ob-
served, even at high concentrations (100 mm) of these com-
pounds. This system can be used to detect cocaine in human
serum.
Recently, Wang and co-workers have developed a new co-
caine naked-eye detection method (Figure 35) by using paper
microfluidic strips (PADs) coupled with gold nanoparticles and
two cocaine aptamers (ACA-1 and ACA-2).[74] The PADs are fab-
ricated by using a commercial wax printer to form three cham-
bers (with different diameters) on the surface of chromato-
graphic paper Whatmann No.1. More in detail, the chromato-
graphic strip has, at the upper part, a chamber that contains
2 nmol AuNPs. In the middle chamber, ACA-1 and ACA-2
(0.6 nmol each) are placed. Finally, there is a chamber at the
bottom of the strip for the samples. After adding the sample
in the bottom chamber, the prepared test strip is placed in a
carrier solution containing 2.8m MgCl2/50 mgmL
@1 sucrose
(300 mL). It is known that free aptamers can bind to the surface
of AuNPs, preventing them from aggregating even in the pres-
ence of concentrated salts (red color). However, in the pres-
ence of cocaine, these aptamers bind to cocaine, leaving the
AuNPs free to aggregate. The authors find that even at low
concentrations of cocaine (10 mg) the carrier solution passes
through the aptamer zone to the location of the AuNPs and
the color changes from pink-red to gray in 5 min. In contrast,
in the absence of cocaine, the moving solution arrives at the
end of the strip and the AuNPs area remains red, which can be
noted by the naked eye. The limit of detection for cocaine re-
ported for this system is 2.5 mg. Besides, a high selectivity over
other illicit drugs such as ephedrine, codeine, ketamine, am-
phetamine, morphine, and methamphetamine can be ach-
ieved. Furthermore, metabolites of cocaine, benzoylecgonine,
and ecgonine methyl ester are unable to induce a color
change.
Liu and Lu present a method for the detection of cocaine
on the basis of the colorimetric change observed upon disas-
sembly of AuNPs functionalized with different thiol-modified
DNA sequences connected to a complementary DNA sequence
(linker) and to the corresponding analyte aptamer.[75] In the ab-
sence of cocaine, gold nanoparticles form aggregates of thou-
sands of nanoparticles (blue color due to an absorbance band
centered at l=700 nm). However, in the presence of this drug,
these nanoparticles separate from each other because of a
conformational change in the aptamer upon binding to co-
caine (Figure 36), and this changes the color of the solution to
red (absorbance at l=522 nm). Characterization by transmis-
Figure 34. Schematic representation for cocaine detection through modified
aptamers grafted onto an optical fiber biosensing platform.
Figure 35. Schematic representation for cocaine detection by using AuNPs
and aptamers.
Figure 36. Cocaine detection through aptamer conformation changes in the
presence of the drug.
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sion electron microscopy after/before cocaine addiction con-
firms the disaggregation of the nanoparticles. Cocaine can be
quantified in the range of 50 (LOD) to 500 mm within a 10 s
period.
Liu et al. reported in 2016 a portable up-conversion nano-
particle (UCNP)-based paper device for cocaine detection.[76]
The paper device is functionalized with polyethylenimine (PEI)-
coated UCNPs and with the amine-modified ACA-1 fragment
of the cocaine aptamer. Besides, another fragment of cocaine
aptamer (ACA-2) bearing a thiol moiety is grafted onto the ex-
ternal surface of 16 nm AuNPs (Figure 37). In the presence of
cocaine, both DNA fragments (ACA-1 and ACA-2) reassemble,
and the luminescence of the UCNPs is quenched by the prox-
imity of the AuNPs. This quenching effect can be attributed to
the perfect match of the emission of the UCNPs and the ab-
sorption of the AuNPs and can be observed by the naked eye
for qualitative analysis or recorded by a smartphone to convert
data into RGB intensity for quantification. The limit of detec-
tion for cocaine is 10 nm, whereas in human saliva the mini-
mum amount detected is 0.05 mm. Besides, recoveries in the
89–103% range can be measured for cocaine-spiked samples
of human saliva. On the other hand, neither ecgonine methyl
ester nor benzoylecgonine induce any emission change.
Yu and co-workers report a cocaine detection method based
on graphene oxide (GO) and on polymerase-aided isothermal
circular strand-displacement amplification (ICSDA) combined
with the use of the dye SYBR Green I (SGI).[77] The authors pre-
pare a hairpin probe consisting of two different DNA frag-
ments: 1) a cocaine aptamer; 2) a region designed to hybridize
with a primer. In the absence of cocaine, the 3’-phosphorilated
end of the hairpin probe oligonucleotide chain avoids poly-
merase elongation, whereas in the presence of the drug a con-
formational change exposes the 3’-single-stranded tail that hy-
bridizes with the primer and allows initiation of the poly-
merase chain reaction. This process forms large amounts of
dsDNA, with low affinity toward GO, which intercalates the SGI
dye, and its fluorescence is observed. In addition, in the ab-
sence of cocaine, dsDNA is not formed, and the hairpin probe
and SGI are adsorbed onto GO with subsequent quenching of
the emission of the fluorophore (Figure 38). The limit of detec-
tion for cocaine is estimated to be 190 nm, and the linear
range is from 0.2 to 100 mm. Weak fluorescence emission in
the presence of adenosine, caffeine, theophylline, and mor-
phine hydrochloride is observed. Finally, good linear correla-
tion from 0.5 to 100 mm is achieved for cocaine-spiked real
urine samples (20-fold dilution).
Yagci and co-workers assess a double fluorescence microwell
assay that combines QDs labeled with cocaine antibodies with
a polyphenylene-based polymer (PPP) containing b-cyclodex-
trins (CDs) derivatized with poly(ethylene glycol) (PEG) chains
(Figure 39).[78] The PPP-CD-g-PEG polymer can be synthesized
by a Suzuki coupling reaction. In this polymer, the hydropho-
bic cavity of the CD is envisioned as a cocaine recognition site,
whereas the PEG chains provide water solubility. The surface of
the microwell is modified by grafting of the PPP-CD-g-PEG
polymer. Cocaine forms inclusion complexes with the CD in
the polymeric backbone. Then, the QDs are added, and they
coordinate with cocaine through selective interaction of the
drug with the antibodies that coat the nanoparticles. As a con-
sequence, the emission of the QDs centered at l=655 nm
(lex=400 nm) is enhanced. Besides, the intrinsic fluorescence
emission of PPP-CD-g-PEG at l=410 nm (lex=330 nm) is
quenched by the adsorbed QDs. By using this methodology, a
linear range from 10 to 100 nm of cocaine with a limit of de-
tection of 13.35 nm is obtained. Negligible response is ob-
tained in the presence of methamphetamine, codeine, tetrahy-
drocannabinol, nicotine, cotinine, and benzoylecgonine. Finally,
synthetic serum samples spiked with known cocaine amounts
have been analyzed, and the results obtained have been com-
pared to those obtained by using LC–MS/MS; good agreement
is observed.
Figure 37. Luminescence quenching effect due to energy transfer between
PEI-UCNPs and AuNPs if cocaine is present.
Figure 38. Representation of cocaine aptasensors combining GO, aptamers,
and polymerase activity.
Figure 39. Schematic representation of the double fluorescence assay de-
signed for the detection of cocaine.
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Hu et al. present a novel colorimetric cocaine biosensor
based on Au@Ag core–shell nanoparticles (Figure 40).[79] For
this purpose, Au@Ag nanoparticles are functionalized with a
ssDNA reporter (RP), and then, magnetic beads (MBs) are pre-
pared and coated with a capture ssDNA (CP). RP and CP are
designed to present complementarity with the cocaine apta-
mer. In the absence of cocaine and in a solution containing its
aptamer, RP-functionalized Au@Ag nanoparticles and CP-
coated MBs aggregate and can be removed upon application
of an external magnetic field. However, if cocaine is present, its
selective coordination with the aptamer inhibits nanoparticle
aggregation, and the solution remains yellow (absorbance of
the nanoparticles centered at l=400 nm). With this protocol,
the limit of detection for cocaine is 0.5 nm with a linear re-
sponse of 0.5 to 200 nm. The system does not respond to the
presence of other illicit drugs such as ketamine, norketamine,
morphine, cathinone, methacathinone, 3-trifluoromethyphenyl-
piperazine, and MDA. A similar biosensor can be prepared for
sensing methamphetamine with a limit of detection of 0.1 nm.
Leung and co-workers describe a label-free switch-on lumi-
nescent sensor for the detection of cocaine.[80] The authors
design two DNA oligomers composed of a fragment of the co-
caine aptamer and a fragment able to form G-quadruplex
structures. In the presence of both cocaine and an iridium
complex, the two aptamer fragments came together to allow
the formation of a G-quadruplex structure, which gives a lumi-
nescent response. The ability to form the G-quadruplex struc-
ture with different iridium complexes has been studied. The
best response is observed with 45
(Figure 41), as the size and shape
of the N^N ligand is crucial for
construction of the G-quadruplex
structure. The limit of detection of
the aptasensor with complex 45
for cocaine is 30 nm. Besides, the
aptasensor is selective for cocaine
in the presence of adenosine tri-
phosphate, adenosine, warfarin,
and suramin. Moreover, the forma-
tion of the G-quadruplex structure with other planar molecules
such as ochratoxin A, thiazole orange, protoporphyrin IX, crys-
tal violet, thioflavin T, and adenosine triphosphate has been
studied, and only a weak luminescence response is observed.
Du et al. report a simple and sensitive DNAzyme-based col-
orimetric sensor for cocaine detection by using the 3,3,5,5-tet-
ramethylbenzidine sulfate (TMB)/H2O2 reaction system.
[81] For
this purpose, the amino groups of functionalized magnetic
nanoparticles (MNPs) are linked covalently to a thiolated co-
caine aptamer fragment (C2). On the other hand, another co-
caine aptamer fragment is extended with a G-enriched strand
AG4 (C1-AG4). In the presence of cocaine, the C2 layer on the
MNPs hybridizes partly with C1-AG4 to result in the folding of
the aptamer into a three-way junction on the surface of the
MNPs to form a MNPs-C2–cocaine–C1-AG4 complex. Using an
external magnet, the nanoparticles can be separated from the
solution (Figure 42). Then, the addition of hemin to the MNPs-
C2–cocaine–C1-AG4 complex promotes the formation of a
DNAzyme, which catalyzes the TMB/H2O2 reaction system to
yield a change in the color of the solution from colorless to
yellow. In the absence of cocaine, the separated MNPs do not
include C1-AG4; thus, no background signal can be produced.
Using these aptasensors, drug concentrations of 100 nm can
be directly detected by the naked eye, with a limit of detection
of 50 nm. Besides, this protocol shows high selectivity for co-
caine over ecgonine, pethidine, and methadone, which do not
induce any color changes.
Silver nanoclusters (AgNCs) can be used as an indicator for
cocaine detection in the presence of DNA templates utilizing
the advantages of the nicking endonuclease-assisted signaling
amplification (NEASA) strategy (Figure 43).[82] The reported ap-
tasensor consists of three different DNA sequences, DNA1,
DNA2, and DNA3. The first one is designed to contain three
domains: the cocaine aptamer, a sequence that is complemen-
tary to DNA2, and a nicking endonuclease (Nb.BbvCI) enzyme
recognition sequence. On the other hand, DNA2 includes two
AgNCs template segments (coordinates with metallic AgNCs)
Figure 40. Schematic illustration of the mechanism for the detection system
based on gold nanoparticles core–shell functionalized with aptamers.
Figure 41. Chemical structure
of iridium complex 45.
Figure 42. Colorimetric assay for cocaine detection by using aptamers,
hemin, and TMB.
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and the recognition sequence and cleavage site for Nb.BbvCI.
Finally, DNA3 is designed to be partly complementary to both
ends of DNA2. It must be noted that the free AgNC template
segments act as a scaffold for the synthesis of fluorescent
silver nanoclusters in the presence of Ag+ through its reduc-
tion with NaBH4. Therefore, in the absence of cocaine, DNA3
and DNA2 undergo hybridization to form a closed circular
structure that keeps the AgNC template segment in a rigid
stage that cannot combine with Ag+ to form the fluorescent
silver nanoclusters. However, the addition of cocaine to the so-
lution induces opening of the structure due to the binding of
cocaine to its specific aptamer; thus, hybridization between
the three DNAs to form a DNA1–DNA2–DNA3 complex is facili-
tated. Then, selective enzymatic cleavage of the DNA2–DNA3
duplex by Nb.BbvCI results in the release of free AgNC tem-
plate segments, and this induces the synthesis of fluorescent
silver nanoclusters. The aptasensor shows high selectivity for
cocaine over other common interferences such as ecgonine
and benzoylecgonine. The prepared aptasensor presents a
linear range from 2 nm to 50 mm cocaine with a limit of detec-
tion as low as 2 nm. Besides, the probe is able to detect co-
caine in human serum with very high recovery values of
around 98 to 99.8%.
Zhou and co-workers outline the construction of a new opti-
cal aptasensor for cocaine detection.[83] The system is based on
a fluorescein isothiocyanate (FITC)-labeled aptamer that produ-
ces a conformational change from a partial single-stranded
DNA to a double-stranded T-junction in the presence of co-
caine (Figure 44). This change facilitates a minor-based energy
transfer (MBET) between the FITC-labeled 3’-end of the apta-
mer and Hoechst 33342 bound to the double-stranded T-junc-
tion, and this leads to fluorescence emission at l=520 nm
(lex=360 nm). The authors test the response of the aptasensor
with benzoylecgonine and ecgonine methyl ester. None of the
selected interfering chemicals induce any emission change.
Furthermore, the limit of detection for cocaine is 0.2 mm.
Taking into account the previously exposed works, several
strategies have been used to develop chromo- and fluorogenic
probes for stimulant drugs, namely: 1) the formation of fluores-
cent complexes; 2) antibody-based systems; 3) the use of
nanoparticles; 4) derivatization reactions; 5) spectral fluores-
cent signatures; 6) aptamer-based methods.
The formation of fluorescent complexes is one of the most
exploited strategies. Probes reported within this approach
change or enhance the fluorescence emission almost instanta-
neously and are easy to handle; some of them have the ability
to detect drugs in the vapor phase, which considerably in-
creases their potential use as a detection method in realistic
settings. Besides, some of them can be fixed over surfaces.
However, some limits of detection are relatively high, and
some of the reported examples work in organic solvents or in
mixed aqueous solutions. Several examples have high potential
for real applicability. For instance, sensing strips for the naked-
eye detection of cocaine by using antibodies and associated to
a mobile app for quantification of the drug have been de-
scribed. Sensory systems based on porous nanoparticles
loaded with dyes/fluorophores show signal amplification fea-
tures and allow drug detection in the vapor phase. Chemical
derivatization of drugs with the aim to confer fluorescence to
the final molecules is another widely followed strategy. The
used reactions are fast and reliable, and some of the protocols
described also include the use of mobile technology. In spite
of these positive facts, none of the described examples based
on this approach can detect drugs in the vapor phase. Other
approaches involve the use of spectral fluorescence signature
(SFS) measurements and artificial neuron networks for data
treatment. This approach presents some drawbacks, such as
the need for learning and validation steps and its complicated
translation into an in-field system measurement. Moreover, a
large percentage of the published examples dealing with the
detection of well-known abuse drugs (such as cocaine and
methamphetamine) are based on the use of aptamers (alone
or grafted onto organic/inorganic supports). The selectivity
Figure 43. Schematic representation of fluorescent Ag nanocluster formation
in the presence of cocaine.
Figure 44. Scheme for cocaine detection by using aptamers grafted onto
polydimethylsiloxane glass. In the presence of cocaine, the aptamer adopts
a specific conformation that interacts with Hoechst 33342. This dye restores
FITC emission.
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achieved with the use of aptamers is very remarkable. Besides,
several aptamer-based detection systems are coupled with
DNA replication processes for signal amplification, allowing
very low limits of detection in the nanomolar range. However,
from a technological point of view, these aptamer-based sen-
sors are usually more expensive and complex than others de-
scribed above.
4. Hallucinogenic Drugs
Hallucinogenic drugs include cannabis, psilocybin, lysergic acid
diethylamide (LSD), peyote, and dimethyltryptamine (DMT),
among others.[84] Historically, some of these drugs have been
used for religious rituals. They cause the consumer to see and
hear inexistent and unreal things, which causes the consumers
to feel out of control or disconnected from their body and en-
vironment. Specifically, some of their most prominent effects
occur in the prefrontal cortex-an area involved in mood, cogni-
tion, and perception, as well as other important regions in reg-
ulating arousal and physiological responses to stress and
panic. These drugs can be found in some plants and mush-
rooms or can be man made. LSD, psilocybin, and DMT produce
their effects through interaction with serotonin (5-HT) recep-
tors. Others, the most, affect the N-methyl-d-aspartate receptor
(NDMA-receptor), the k-opioid receptor (KOR), and the neuro-
transmitter acetylcholine.
Badout and Andre take advantage of the intrinsic fluores-
cent properties of lisergamide (commonly known as LSD) to
develop a low-costing and portable device for its detection.[85]
LSD presents a fluorescence band in the l=400–530 nm
range, depending on the solvent and pH. The apparatus is
constructed to allow the naked-eye detection of LSD by com-
paring the emission of an LSD solution with its corresponding
blank solution upon excitation with a mercury lamp by using
both neutral and 1m NaOH alkali solution as the solvent. If
LSD solutions in neutral water are submitted to the mercury
lamp, a characteristic blue emission is observed. This occurs
also with other hallucinogens such mescaline, 2,5-dimethoxy-4-
methyl amphetamine (DOM), psilocin, psilocybin, bufotenin,
ibogaine, and phencyclidine. However, if they are dissolved in
1m NaOH aqueous solution, only with LSD is a change in fluo-
rescence emission to green observed. The limit of detection
for LSD samples dissolved in neutral water is 50 ng, whereas
that for LSD samples in alkali media increases to 260 ng.
There is only one example reported in this section, and it is
anticipated that new chromo- and fluorogenic probes for the
detection of hallucinogenic drugs will be developed in the
near future.
5. Opiods
Opioids drugs such as heroin, codeine, morphine, fentanyl, hy-
drocodone, oxycodone, buprenorphine, and methadone act
through opioid receptors in the spinal cord and brain.[86] These
compounds have been used for centuries to treat pain, cough,
and diarrhea. Nowadays, medical use is to treat acute pain.
Opioids act by binding to opioid receptors, which are found
principally in the central and peripheral nervous system and
the gastrointestinal tract. The concurrent use of opioids with
other depressant drugs such as benzodiazepines increases the
rates of adverse events and overdose.
Baheri and co-workers propose a colorimetric method for
the selective detection of opioid-based drugs such as mor-
phine, codeine, oxycodone, noroxycodone, thebaine, tramadol,
and methadone in aqueous media on the basis of color
changes produced by the aggregation of AuNPs in the pres-
ence of these analytes that act as molecular bridges between
them (Figure 45).[87] The sensing systems comprise four citrate-
coated AuNPs with different particle sizes (diameters of 13, 23,
32, and 43 nm); these different AuNPs present different aggre-
gation behaviors with selected drugs, which results in a finger-
print pattern in the spectra that can be translated by algorith-
mic pattern recognition [principal component analysis (PCA)
and hierarchical cluster analysis (HCA)] in an array for the clas-
sification, identification, and quantification of these analytes.
For each opioid and particle size, the difference in absorbance
(DA) with the blank is used as a response, and the effects of
critical parameters, such as pH, ionic strength, time of interac-
tion, and analyte concentration, are evaluated. After optimiza-
tion, discrimination of seven opioids is possible, with limits of
detection of about 5 mmolL@1 (except for noroxycodone), and
experiments with several potential interfering substances show
negligible responses. Finally, color-difference maps are ob-
tained before/after exposure for each opioid by using repre-
sentative RGB wavelengths (l=730, 685, and 600 nm), and
they show good accuracy and reproducibility.
Anzenbacher and co-workers present a new approach for
sensing heroine, morphine, oxycodone, and their main metab-
olites on the basis of the interaction of these molecules with
the flexible cavity of fluorescent acyclic cucurbituril (aCBs) de-
rivatives (Figure 46).[88] Three aCBs functionalized with naphtha-
lenes (with different degrees of steric hindrance) in the termi-
nal walls are employed in the sensing protocol. The steric hin-
drance defines the diameter of the recognition cavity in the
aCBs. The guests tested (i.e. heroine, morphine, oxycodone)
share a common skeleton with small structural differences.
Figure 45. Schematic representation for the colorimetric detection of opioid
drugs through AuNP color changes produced by nanoparticle aggregation.
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Host–guest recognition results in fluorescence modification of
the terminal naphthalene emission, and this induces a “turn-
on” response for morphine and heroine as a consequence of
the increased rigidity. However, in the case of oxycodone, and
due to the quencher effect of cyclohexanone on naphthalenes,
the fluorescence emission is diminished. Molecular dynamics
calculations confirm that the naphthalene walls and the resul-
tant cavity as well as guest uptake are decisive factors for fluo-
rescence detection. The induced responses of these organic
sensors with the studied opiates differ in the amplitude and
saturation of the fluorescence change, in that the sensors all
present different binding isotherms, and this suggests that
they act as cross-reactive sensors. Furthermore, these organic
probes show different behaviors for the studied parent drugs
(i.e. morphine, heroin, and oxycodone) and their metabolites
(i.e. normorphine, 6-monoacetylmorphine, morphine-3-glucur-
onide, morphine-6-glucuronide, noroxycodone, and oxymor-
phone), which makes it possible to determine both in a specif-
ic, qualitative, and quantitative manner. A qualitative assay has
been performed in a high-throughput fashion by using linear
discriminant analysis (LDA) for pattern recognition, and it
shows three clusters consisting of the parent drugs and their
corresponding metabolites. A general calibration makes it pos-
sible to detect the components of the clusters simultaneously
with a single fluorescent reading. The limits of detection in
aqueous media are 0.07 ppb for morphine and 82.5 and
2.78 ppb for the morphine metabolites morphine-3-glucuro-
nide (M3G) and normorphine (Nmor), respectively. In human
urine samples spiked with selected components, the limits of
detection are 27.5, 972, and 71.3 ppb for morphine, M3G, and
Nmor, respectively.
Only a few examples of chromo- and fluorogenic sensors for
the detection of individual opioids have been described by
now, and new examples in this area are expected to be report-
ed in the future.
6. Conclusions
The problematic use of illicit drugs (both plant-based and syn-
thetic derivatives) associated with their harmfulness to health
and mortality has urged the scientific community to develop
reliable methodologies to detect and quantify these lethal sub-
stances. We have herein reviewed probes for the chromo- and
fluorogenic detection of illicit drugs. These probes (which can
be simple molecules of more sophisticated systems involving
biomolecules or hybrid organic–inorganic materials) provide
excellent advantages over traditional analytical techniques,
such as their chemical simplicity, ease of use, rapid response
suitable for real-time on-site detection, and easy detection (in
certain cases to the naked eye). However, in spite of these re-
markable features, the development of chromo- and fluoro-
genic probes for the selective and sensitive detection of some
illicit drugs is still poorly explored. In fact, more than half of
the described chromo- and fluorogenic probes have been de-
signed for the recognition/quantification of common plant-
based drugs (such as cocaine), yet relatively few works de-
scribe the preparation of sensing systems for the detection of
new synthetic illicit drugs. In addition, most chromo- and fluo-
rogenic detection systems are designed for the detection of il-
licit drugs in solution, and there are very few examples for
their detection in the vapor phase. Moreover, with the increas-
ingly ubiquitous internet and other methods of communica-
tion, the presence of illicit drugs has expanded in recent years.
As these synthetic drugs have not been approved for con-
sumption or medical use, their long-term effects are potentially
severe for humans. In this scenario, the development of new,
rapid, inexpensive, and easy-to-use new probes for these new
substances is of importance, and new advances in this field are
expected in the near future.
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